Votes at a glance: Health Care & Wellness committee Feb. 25 actions
February 25, 2026 | Legislative Sessions, Washington
This article was created by AI summarizing key points discussed. AI makes mistakes, so for full details and context, please refer to the video of the full meeting. Please report any errors so we can fix them. Report an error »
The Health Care and Wellness committee took final committee votes on seven bills on Feb. 25. Below are the items the committee reported out with the committee’s recommendation and the vote outcomes as announced by staff.
- ESHB 53‑95 (prior authorization): Reported out with a due‑pass recommendation. Announced tally: 16 ayes, 2 nays, 1 excused.
- SSB 59‑81 (340B reporting/fee framework): Reported out as amended with a due‑pass recommendation. Announced tally: 11 ayes, 7 nays, 1 excused.
- SSB 55‑94 (biosimilars): Reported out with a due‑pass recommendation (expedited voice vote). Announced tally: 18 ayes, 0 nays, 1 excused.
- SSB 58‑77 (certified anesthesiology assistants / Physician Health Program): Reported out with a due‑pass recommendation (voice vote). Announced tally: 18 ayes, 0 nays, 1 excused.
- SSB 61‑83 (coverage for all FDA‑approved HIV antivirals without utilization management): Reported out with a due‑pass recommendation (expedited voice vote). Announced tally: 18 ayes, 0 nays, 1 excused.
- SSB 62‑10 (health benefit exchange market factor criteria): Reported out as amended with a due‑pass recommendation. Announced tally: 11 ayes, 7 nays, 1 excused.
- SSB 6,226 (Board of Hearing and Speech; standards for hearing aids): Reported out as amended with a due‑pass recommendation. Announced tally: 17 ayes, 1 nay, 1 excused.
All items were reported out to the next legislative stage with the committee’s due‑pass recommendations. The committee adjourned at the conclusion of its business.
- ESHB 53‑95 (prior authorization): Reported out with a due‑pass recommendation. Announced tally: 16 ayes, 2 nays, 1 excused.
- SSB 59‑81 (340B reporting/fee framework): Reported out as amended with a due‑pass recommendation. Announced tally: 11 ayes, 7 nays, 1 excused.
- SSB 55‑94 (biosimilars): Reported out with a due‑pass recommendation (expedited voice vote). Announced tally: 18 ayes, 0 nays, 1 excused.
- SSB 58‑77 (certified anesthesiology assistants / Physician Health Program): Reported out with a due‑pass recommendation (voice vote). Announced tally: 18 ayes, 0 nays, 1 excused.
- SSB 61‑83 (coverage for all FDA‑approved HIV antivirals without utilization management): Reported out with a due‑pass recommendation (expedited voice vote). Announced tally: 18 ayes, 0 nays, 1 excused.
- SSB 62‑10 (health benefit exchange market factor criteria): Reported out as amended with a due‑pass recommendation. Announced tally: 11 ayes, 7 nays, 1 excused.
- SSB 6,226 (Board of Hearing and Speech; standards for hearing aids): Reported out as amended with a due‑pass recommendation. Announced tally: 17 ayes, 1 nay, 1 excused.
All items were reported out to the next legislative stage with the committee’s due‑pass recommendations. The committee adjourned at the conclusion of its business.
View the Full Meeting & All Its Details
This article offers just a summary. Unlock complete video, transcripts, and insights as a Founder Member.
✓
Watch full, unedited meeting videos
✓
Search every word spoken in unlimited transcripts
✓
AI summaries & real-time alerts (all government levels)
✓
Permanent access to expanding government content
30-day money-back guarantee
